Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030

被引:1
作者
V. Kim, Thanh [1 ,2 ]
Pham, Trang N. D. [3 ,4 ]
Le, Duc H. [1 ]
Dao, Diem V. B. [4 ]
Phan, Loc T. B. [4 ]
Le, Anh [4 ]
Trang, Amy [4 ]
Tang, Hong K. [1 ]
Liu, Jason J. [2 ,5 ,7 ]
Dao, Doan Y. [4 ,6 ,8 ]
机构
[1] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam
[2] Natl Yang Ming Chiao Tung Univ, Coll Med, Int Hlth Program, Taipei, Taiwan
[3] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[4] Vietnam Viral Hepatitis Alliance, Reston, VA USA
[5] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan
[6] Johns Hopkins Univ, Ctr Excellence Liver Dis Viet Nam, Sch Med, Baltimore, MD USA
[7] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Med Bldg II,155,Sect 2,Linong St, Taipei, Taiwan
[8] Johns Hopkins Univ, Sch Med, Ross Res Bldg,Room 310,720 Rutland Ave, Baltimore, MD 21205 USA
关键词
Hepatitis B virus; Vaccination; Elimination; Survey; Adult; Viet Nam; Lower-middle-income country; INFECTION; VIRUS;
D O I
10.1016/j.vaccine.2022.12.051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Gaps in adult hepatitis B vaccination were undefined in Vietnam, a lower-middle-income country. To address these gaps, this study defined hepatitis B vaccine coverage in adults and its associated factors in Ho Chi Minh City (HCMC), Viet Nam. We also proposed interventional strategies, prioritizing gap identification to facilitate hepatitis B elimination by 2030 and beyond.Method: During 2019-2020, a multi-stage cluster serosurvey with probability proportional to size was conducted to representatively invite 20,000 adults (18 years or older) throughout HCMC for hepatitis B screening (HBsAg, anti-HBs, and anti-HBc). Serologic results defined two dependent variables: vaccine -induced immunity (i.e., isolated anti-HBs) and susceptibility (i.e., HBV naive). Associations of dependent variables with surveyed demographics, socioeconomic statuses, behaviors, and medical history at risk for hepatitis B were evaluated using weighted Poisson regression.Results: The prevalence was 18.5% (95%CI, 17.3-20.0%) for vaccine-induced immunity and 37.7% (35.6-39.8%) for susceptibility. Even though analyses in the general population revealed a falling trend in vaccine-induced immunity prevalence from younger to older age groups, sensitivity analyses in the non-infected population (i.e., those who were both negative for HBsAg and anti-HBc) showed that younger age groups, especially those aged 30 to 50 years, had the lowest prevalence. Social inequalities existed in different ethnicities, residence areas, education levels, house ownership, and health insurance statuses. There was no significant association between vaccine-induced immunity or susceptibility and risky behaviors and medical histories.Conclusion: This study depicts a significant unmet need for hepatitis B vaccination in the general adult population in HCMC, Viet Nam. Indeed, the lack of vaccination was unevenly distributed regarding age groups, geographical areas, and socioeconomic statuses, which reveals profound social disparities. Therefore, to achieve hepatitis B elimination goals, besides the current recommendations for infants and risk-based strategies, hepatitis B vaccination should be recommended for the broader population.(c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页码:976 / 988
页数:13
相关论文
共 50 条
  • [21] Response to hepatitis B vaccination among HIV-infected adults in Vietnam
    Pollack, Todd M.
    Le Thi Thu Trang
    Long Ngo
    Do Duy Cuong
    Pham Thanh Thuy
    Colby, Donn J.
    [J]. JOURNAL OF VIRUS ERADICATION, 2016, 2 (02) : 102 - 106
  • [22] How important is early childhood hepatitis B vaccination? a survey of primary care physicians
    Zimmerman, RK
    Mieczkowski, TA
    [J]. JOURNAL OF FAMILY PRACTICE, 1998, 47 (05) : 370 - 374
  • [23] Hepatitis B Knowledge,Testing, and Vaccination Among Chinese and Vietnamese Adults in Australia
    Vu, Lan H.
    Gu, Zhihong
    Walton, Jodie
    Peet, Anthony
    Dean, Judith
    Dunne, Michael P.
    Debattista, Joseph
    [J]. ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2012, 24 (02) : 374 - 384
  • [24] Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis
    Ghaswalla, Parinaz K.
    Patterson, Brandon J.
    Cheng, Wendy Y.
    Duchesneau, Emilie
    Macheca, Monica
    Duh, Mei Sheng
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (11) : 2780 - 2785
  • [25] Progress toward elimination of hepatitis B virus transmission in the United States
    Mast, EE
    Mahoney, FJ
    Alter, MJ
    Margolis, HS
    [J]. VACCINE, 1998, 16 : S48 - S51
  • [26] Targeted antiviral treatment of hepatitis B virus in culturally and linguistically diverse populations to achieve elimination targets in Australia
    Taye, Belaynew W.
    Valery, Patricia C.
    Clark, Paul J.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2022, 29 (10) : 868 - 878
  • [27] Clinical factors associated with hepatitis B screening and vaccination in high-risk adults
    Ayoola, Rotimi
    Larion, Sebastian
    Poppers, David M.
    Williams, Renee
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2019, 11 (01) : 86 - 98
  • [28] Conference Report - Recommendations from the Forum for Collaborative Research Symposium on hepatitis B elimination and universal hepatitis B adult vaccination in the United States
    Leus, Mitchell
    Treat, Mayland
    Miller, Veronica
    Reingold, Arthur
    [J]. JOURNAL OF VIRUS ERADICATION, 2024, 10 (02)
  • [29] Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults
    Kakisaka, Keisuke
    Sakai, Aiko
    Yoshida, Yuichi
    Miyasaka, Akio
    Takahashi, Fumiaki
    Sumazaki, Ryo
    Takikawa, Yasuhiro
    [J]. INTERNAL MEDICINE, 2019, 58 (16) : 2349 - 2355
  • [30] Immune Determinants in the Acquisition and Maintenance of Antibody to Hepatitis B Surface Antigen in Adults After First-Time Hepatitis B Vaccination
    Doi, Hiroyoshi
    Yoshio, Sachiyo
    Yoneyama, Keiichiro
    Kawai, Hironari
    Sakamoto, Yuzuru
    Shimagaki, Tomonari
    Aoki, Yoshihiko
    Osawa, Yosuke
    Yoshida, Hitoshi
    Kanto, Tatsuya
    [J]. HEPATOLOGY COMMUNICATIONS, 2019, 3 (06) : 812 - 824